Every bank knows which products it sells. Far fewer can say which ones earn their place, which are quietly subsidised by the rest, and what would have to be true for the next bet to work. EvoluWise makes that conversation possible — with evidence, and with a memory.
A product committee meets, opinions are exchanged, a call is made. Six months later nobody remembers what the decision assumed — only whether it worked.
Each product read on the same basis — what it costs to run, what it brings in, who it actually serves.
Turn an intention into conditions: the volume, the margin, the adoption a decision depends on.
Keep, rework, merge or stop — each option carrying its own assumptions rather than a single forecast.
What was decided, on what basis, and what the reality turned out to be. The next decision starts from there.
EvoluWise is not a reporting tool for analysts. It is built for the room where the decision is actually taken, and for the disagreements that happen in it.
Owns the portfolio and the arbitration. Needs a defensible basis, not a slide.
Brings adoption reality and customer segments into the same frame as the numbers.
Wants product-level economics that hold up when challenged.
Needs the conditions and the constraints written down before, not discovered after.
A working prototype, a canonical model of how a portfolio decision is structured, and the reference documents behind it.
V0 in design, and validation conversations with banks and with the vendors already serving them — because that is how this product reaches a bank.
No client yet. The economics are estimates, not measured cohorts. We would rather say that than discover it in a pilot.
The one that keeps being postponed, or the one nobody agrees on. That is the right place to start.